QSER1 (glutamine and serine rich 1) is an essential epigenetic regulator that protects developmental gene expression through DNA methylation control. Functionally, QSER1 serves as a guardian of bivalent promoters and poised enhancers, particularly those residing in DNA methylation valleys 1. Mechanistically, QSER1 cooperates with TET1 and binds DNA within a common complex to inhibit DNMT3A/3B-mediated de novo methylation 1. This protective function extends to maintaining transcriptional programs essential for early development, with QSER1 identified as a phase-specific factor in pluripotency regulation 2. QSER1 also functions as a developmental regulator through interactions with YAP1/TEAD4 enhancers, where it suppresses RNA Polymerase II recruitment to control lineage genes like NODAL 3. In cancer contexts, QSER1 is frequently upregulated and prevents apoptosis by suppressing pro-apoptotic genes (e.g., PUMA) through cooperation with SIN3A 4, correlating with poor clinical outcomes. Disease relevance is demonstrated by heterozygous QSER1 variants causing neurodevelopmental phenotypes with multisystem anomalies including developmental delay, cardiac defects, and structural eye abnormalities 5. Additionally, QSER1 has been identified as a candidate gene in type 2 diabetes mellitus susceptibility 6, though its specific mechanisms in metabolic disease require further investigation.